Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > So we go to the gate...

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on May 04, 2021 7:39am

100 Views

Post# 33121754

RE:RE:RE:So we go to the gate...

Well said.

longterm56 wrote:

realitycheck4u wrote: Do you think the new investors like Soleus are going to accept another crapp deal like we just ate? No. They will not. They would vote with us.

uhhh, I don't remember being asked to vote on the OO, and we won't be asked to vote on the next offering ... which is less than a year away since they are increasing their spending and their two commercial drugs are not selling (despite PLs promises).

This BOD is capable of doing much more harm to us longterm shareholders ... and our only vote is who is on the BOD, not each offering or other significant decision. IT'S THE ONLY OPTION WE HAVE.

-LT